The Bethesda, Md.-based National Cancer Institute awarded PLx Pharma a $1.9 million grant to support the drugmakers' aspirin for chemoprevention to treat colorectal cancer.
GI & Endoscopy
Here are the five most read gastroenterology/endoscopy stories from May 8 to May 12, 2017.
Here are eight gastroenterologists making headlines the week of May 8, 2017.
Dino Ferrante, MD, is a gastroenterologist at the Huntsville, Ala.-based Center for Colon & Digestive Disease.
A study presented at Digestive Disease Week 2017 examined the effectiveness of an underwater colonoscopy technique, Medscape reports.
Advertisement
University of Chicago Medicine created ILColonCARES.org to help providers schedule colorectal cancer screenings for residents aged 50-years-old to 75-years-old.
Synthetic Biologics' C. difficile drug, ribaxamase, achieved its primary endpoint in a phase 2b trial.
A study presented at Digestive Disease Week examined how patient genotyping with advanced cirrhosis from hepatitis C virus could help healthcare professionals predict likelihood of improvement after treatment.
A study presented at Digestive Disease Week examined the effectiveness of non-surgical endoscopic sleeve gastroplasty in individuals struggling with obesity who are not candidates for weight loss surgery.
Check-Cap and GE Healthcare achieved their first development milestone when GE's developed and tested X-rays passed all tests to ensure C-scan system compliance.